Footprint Pharma ApS: Financial statements 2018
CVR: 37165174
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Footprint Pharma ApS (CVR 37165174) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -367,563 and a net result of DKK -367,563 compared with DKK -143,720 the year before. Equity in the 2018 report amounted to DKK 532,437. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK -367,563
- Profit/Loss
- DKK -367,563
- Equity
- DKK 532,437
- Total Assets
- DKK 532,437
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 0 | -368 t. | -368 t. | 532 t. | - |
| 2017 | 0 | -144 t. | -144 t. | 760 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Footprint Pharma ApS has published its annual report for 2017. Revenue came to DKK 0, and the net result was DKK -143,720.
About Footprint Pharma ApS
Footprint Pharma ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2015. The company has been dissolved on 26 November 2021. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named vHL Group ApS. In 2020, the company reported a gross profit of DKK -1,263 and a net result of DKK 5,851 compared with DKK -59,461 the year before. Equity in the 2020 report amounted to DKK 466,267.